Deutsche Bank Downgrades General Mills to Hold, Announces $88 Price Target
Deutsche Bank analyst Steve Powers downgrades General Mills (NYSE:GIS) from Buy to Hold and announces $88 price target.
Deutsche Bank Downgrades Molson Coors Beverage to Sell, Announces $50 Price Target
Deutsche Bank analyst Steve Powers downgrades Molson Coors Beverage (NYSE:TAP) from Hold to Sell and announces $50 price target.
Deutsche Bank Downgrades Flowers Foods to Sell, Lowers Price Target to $27
Deutsche Bank analyst Steve Powers downgrades Flowers Foods (NYSE:FLO) from Hold to Sell and lowers the price target from $28 to $27.
RBC Capital Downgrades Equitable Holdings to Sector Perform, Lowers Price Target to $33
RBC Capital analyst Mark Dwelle downgrades Equitable Holdings (NYSE:EQH) from Outperform to Sector Perform and lowers the price target from $34 to $33.
Truist Securities Downgrades MEI Pharma to Hold
Truist Securities analyst Robyn Karnauskas downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.
Stifel Downgrades Edwards Lifesciences to Hold, Lowers Price Target to $75
Stifel analyst Rick Wise downgrades Edwards Lifesciences (NYSE:EW) from Buy to Hold and lowers the price target from $95 to $75.
UBS Downgrades Steel Dynamics to Neutral
UBS analyst Andreas Bokkenheuser downgrades Steel Dynamics (NASDAQ:STLD) from Buy to Neutral.
Credit Suisse Downgrades Kymera Therapeutics to Neutral, Lowers Price Target to $32
Credit Suisse analyst Richard Law downgrades Kymera Therapeutics (NASDAQ:KYMR) from Outperform to Neutral and lowers the price target from $47 to $32.
Johnson Rice Downgrades EOG Resources to Hold, Lowers Price Target to $163
Johnson Rice analyst Charles Meade downgrades EOG Resources (NYSE:EOG) from Buy to Hold and lowers the price target from $177 to $163.
Credit Suisse Downgrades VF to Neutral
Credit Suisse analyst Michael Binetti downgrades VF (NYSE:VFC) from Outperform to Neutral.